🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Kyowa Kirin is proud to sponsor #RareDiseaseDay through National Organization for Rare Disorders (NORD). Together we seek to raise awareness of the challenges millions of rare disease patients face. #RareDiseaseDay #ShareYourRare #ShowYourColours #ShowYourStripes

In partnership with Kura Oncology, we are excited to share positive monotherapy registrational study data for our investigational product, ziftomenib and positive FDA feedback for upcoming frontline combination trial designs. See the news release here. bit.ly/3CGYXBx

Cutaneous T-cell lymphoma (#CTCL) is a rare form of blood cancer that impacts the skin. Learn more about this disease that is diagnosed in 3,000 Americans per year: bit.ly/3EqLL4h #RareDiseaseMonth #LookDeeperAtCTCL

Guided by our mission to deliver life-changing value, we empower bright minds like Achilles Vergis to drive meaningful changes in our business. Ready to shape the future of pharma? Apply here: bit.ly/42PV2Nu

At Kyowa Kirin, we engage with and listen closely to our external environment, so as we approach #RareDiseaseDay, we wanted to shine a light on the stories of those affected by rare diseases. #KKIMakingPeopleSmile bit.ly/4i7UmHD

What does it take to have a successful career at Kyowa Kirin? Kelli Shannon shares tips that have served her well on her professional journey. Find your next great job: bit.ly/4375vEb #careers #TeamKyowaKirin

Finding strength in community can help when navigating the challenges of life with a #raredisease. When Sophia was diagnosed with #XLH, her mom knew she needed help. Thanks to support from the community, they no longer feel alone on their journey. #RareDiseaseMonth

Today is #RareDiseaseDay! To show our support, we participated in the @RareDisease's #LightUpForRare campaign and asked our colleagues worldwide to collectively light up for the millions of people who live with a #raredisease. #KKIMakingPeopleSmile #RareDiseaseDay

Big things are happening at #AAD2025! Join Kyowa Kirin and Amgen 🧪🔬🧬 to learn more about our latest research for moderate-to-severe atopic dermatitis. Details here: bit.ly/3FhWTRd

Today, Kyowa Kirin Co., LTD, and Amgen announced topline results for the Phase 3 ROCKET IGNITE trial. bit.ly/3XOyhGa

In partnership with Amgen 🧪🔬🧬, we’re pursuing OX40 research that is providing insights into T-cell imbalance in #atopicdermatitis. #AAD2025 is just the beginning.

We're committed to advancing care for those living with moderate-to-severe #atopicdermatitis. Our research with Amgen 🧪🔬🧬 explores the OX40 receptor's role in T-cell activation driving chronic inflammation. Learn more about the science here: bit.ly/4ixlcte

Heading to Reuters Events Pharma? Don’t miss our very own Debra Jennings, Head of Patient Services Operations for North America and Daniel McNamara, Vice President of Patient Services for North America, take the stage for thought-provoking panels! #ReutersPharmaUSA

We're proud to announce Payal Arora, PhD, as a HBAnet Luminary for advancing women's careers in healthcare! 🎉 Join HBAnet on May 9 in Chicago to celebrate her and fellow trailblazers. #HBAimpact #HBAWOTY25 bit.ly/4aMbXCF @KyowaKirin_US

#Congratulations to all

We are thrilled to announce that Ted Buckley, PhD is joining KyowaKirin_US as Vice President, Government Affairs! Please join us in welcoming Ted to the team! 👏 #KyowaKirin #GovernmentAffairs #Leadership #WelcomeToTheTeam #ProfoundImpact

Like Jiwon, millions of people globally experience the daily challenges of living with moderate to severe #atopicdermatitis. Watch her story to understand the true impact of this disease and the importance of advocating for better care.

On #WorldParkinsonsDay, we honor the strength of those living with Parkinson’s. At Kyowa Kirin, we’re committed to supporting patients and families, raising awareness, and working toward a future of hope. Hear a family’s story bit.ly/44ik1tl 💙 #PatientsFirst

Today on #WorldAMLAwarenessDay, we stand with those impacted by Acute Myeloid Leukemia #AML, a rare and aggressive blood cancer. Kyowa Kirin is proud to partner with @KuraOncology to help accelerate and advance new therapies in the AML space.

This #NationalNursesWeek, we celebrate those who dedicate their lives to care. At Kyowa Kirin, we recognize that nurses bring 💙 compassion, resilience, and expertise to healthcare teams worldwide 🌍 That’s the true #PowerofNurses. 👩🏽‍⚕️👨🏾‍⚕️👩‍⚕️